1,741
Participants
Start Date
May 31, 2006
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Apixaban
Tablets, Oral, 2.5 mg, twice daily, 26 weeks
Apixaban
Tablets, Oral, 10 mg, once daily, 26 weeks
Placebo
Tablets, Oral, 0, twice daily, 26 weeks
Apixaban
Tablets, Oral 10 mg, twice daily, 26 weeks
Local Institution, Vienna
Local Institution, Brussels
Local Institution, Vienna
Local Institution, Frederiksberg
Local Institution, Antwerp
Local Institution, Copenhagen
Local Institution, Glostrup Municipality
Local Institution, Hellerup
Local Institution, Brasschaat
Local Institution, Genk
Local Institution, Huy
Local Institution, Esbjerg
Local Institution, Feldkirch
Local Institution, Herning
Local Institution, Bruges
Local Institution, Arhus C
Local Institution, Aalst
New York Cardiovascular Associates, New York
Local Institution, Berlin
Local Institution, Berlin
Local Institution, Safed
Local Institution, Santiago de Compostela
Local Institution, Nazareth
Penn State Milton S. Hershey Medical Center, Hershey
Geisinger Clinic - Cardiology, Danville
Local Institution, Afula
Local Institution, Dijon
Virginia Commonwealth University, Richmond
Local Institution, León
Wake Forest Univ Health Sciences, Winston-Salem
Unc Hospitals, Department Of Medicine, Chapel Hill
Dumc, Durham
Local Institution, Madrid
Carolina Heart Specialists, Gastonia
Piedmont Cardiology Associates, Hickory
Local Institution, Málaga
Georgia Heart Specialists, Covington
Cardiac Disease Specialists, P.C., Atlanta
Local Institution, Hanover
Local Institution, Haifa
Local Institution, Toulouse
Indian River Medical Center, Vero Beach
Local Institution, Oviedo
Local Institution, Pessac
Watson Clinic Center For Research, Lakeland
Local Institution, Haifa
Heart & Vasc Inst Of Fl, Safety Harbor
Cardiovascular Associates, P.C, Kingsport
Local Institution, Hadera
University Of Kentucky, Lexington
Local Institution, Seville
Local Institution, Tarragona
Midwest Cardiology Research Foundation, Columbus
Local Institution, Nantes
Local Institution, Kfar Saba
The Dayton Heart Center, Dayton
The Care Group, Llc., Indianapolis
Local Institution, Valladolid
Local Institution, Krefeld
William Beaumont Hospital-Troy, Troy
Local Institution, Baracaldo (Vizcaya)
Local Institution, Petah Tikva
Local Institution, Cholet
Iowa Heart Center, Des Moines
Local Institution, Düren
Local Institution, Witten
Local Institution, Roubaix
Heartcare Midwest, Peoria
Local Institution, Langen
Local Institution, Tel Aviv
Local Institution, Ludwigshafen
Oklahoma Cardiovascular Research Group, Oklahoma City
Local Institution, Paris
Tyler Cardiovascular Consultants, Tyler
Local Institution, Rehovot
University Of Texas Medical School - San Antonio, San Antonio
Local Institution, Amiens
South Denver Cardiology Associates, Littleton
Scottsdale Cardiovasular Research Institute, Scottsdale
Los Angeles County & University Of Southern Ca. Medical Cen., Los Angeles
Local Institution, Jerusalem
Local Institution, Jerusalem
Local Institution, Jerusalem
Radiant Research,Santa Rosa, Santa Rosa
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Yaroslavl
Local Institution, Yaroslav
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saint Petersburg
Local Institution, Saratov
Local Institution, Kemerovo
Rhode Island Hospital, Providence
Local Institution, Edmonton
Local Institution, Edmonton
Local Institution, Edmonton
Local Institution, Victoria
Local Institution, St. John's
Local Institution, Belleville
Local Institution, Chatham
Local Institution, Hamilton
Local Institution, London
Local Institution, Oshawa
Local Institution, Montreal
Local Institution, Montreal
Local Institution, Montreal
Local Institution, Saint-Charles-Borromée
Local Institution, Terrebonne
Local Institution, Randers
Local Institution, Halle
Local Institution, Roma
Local Institution, Bialystok
Local Institution, Bydgoszcz
Local Institution, Bydgoszcz
Local Institution, Bydgoszcz
Local Institution, Gdansk
Local Institution, Katowice
Local Institution, Krakow
Local Institution, Krakow
Local Institution, Lodz
Local Institution, Opole
Local Institution, Torun
Local Institution, Warsaw
Local Institution, Zielona Góra
Local Institution, Barcelona
Local Institution, Hospitalet Llobregat Barcelona
Local Institution, Villajoyosa
Local Institution, Gothenburg
Local Institution, Gothenburg
Local Institution, Malmo
Local Institution, Örebro
Local Institution, Stockholm
Local Institution, Sundsvall
Local Institution, Uppsala
Local Institution, Stockport
Local Institution, Harrow
Local Institution, Edinburgh
Local Institution, Portadown
Local Institution, Sheffield
Local Institution, York
Local Institution, Croydon
Local Institution, Leicester
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY